Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2025)

Adaptin Bio (APTN) posted Other Accumulated Expenses of $25000.0 for Q4 2025, up 98.79% sequentially from $12576.0 in Q1 2025.

Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

Adaptin Bio has reported Other Accumulated Expenses for 4 years, with the latest figure at $25000.0 in Q4 2025.

Quarterly Other Accumulated Expenses changed N/A year-over-year to $25000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25000.0 (changed N/A YoY) and the FY2025 annual result came in at $25000.0, changed N/A from the prior year.
Other Accumulated Expenses improved to $25000.0 in Q4 2025 per APTN's latest filing, from $12576.0 in the prior quarter.
Over five years, Other Accumulated Expenses peaked at $44750.0 in Q3 2024 and troughed at $10000.0 in Q4 2023.
A 4-year average of $26296.6 and a median of $25000.0 in 2025 frame the typical range for Other Accumulated Expenses.
The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses plunged 33.33% in 2023, then plunged 65.31% in 2025.
Over 4 years, Other Accumulated Expenses stood at $15000.0 in 2022, then plunged by 33.33% to $10000.0 in 2023, then soared by 347.5% to $44750.0 in 2024, then plunged by 44.13% to $25000.0 in 2025.
According to Business Quant data, Other Accumulated Expenses over the past three periods registered $25000.0, $12576.0, and $44750.0 for Q4 2025, Q1 2025, and Q3 2024 respectively.

Download Data